IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors
Clinical trial NCT03665129 · TERMINATED
Trial details
- NCT number
- NCT03665129
- Sponsor
- Innate Pharma
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-07
- Primary completion
- 2021-02-24
- Enrollment
- 73
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.